New drospirenone/17beta-estradiol regimen, pharmaceutical combination product and kit for performing this regimen

Details for Australian Patent Application No. 2008235006 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Hanes, Vladimir; Blode, Hartmut; Schuermann, Rolf; Duesterberg, Bernd; Marr, Joachim

Agent Davies Collison Cave

Pub. Number AU-A-2008235006

PCT Pub. Number WO2008/122439

Priority 61/040,494 28.03.08 US; 60/910,326 05.04.07 US; 61/035,285 10.03.08 US

Filing date 7 April 2008

Wipo publication date 16 October 2008

International Classifications

A61K 31/585 (2006.01)

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

Event Publications

22 October 2009 PCT application entered the National Phase

  PCT publication WO2008/122439 Priority application(s): WO2008/122439

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008235024-Method for the control of weeds in turf

2008235005-Device for the oral application of a substance